Fremanezumab in Children and Adolescents with...

In part two of this series, Dr. Jeff Ratliff discusses the expanding role of AI and digital tools in neurology education, emphasizing the importance of verifying information and developing source literacy. Show transcript: Dr. Jeff Ratliff: Hi, this is Jeff Ratliff from Thomas Je ...  Show more

Dr. Greg Cooper and Dr. David G. Coughlin discuss the role of αSyn-SAAs in diagnosing DBL and their relationship with Alzheimer's disease biomarkers. Show citation: Coughlin DG, Jain L, Khrestian M, et al. CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers ...  Show more

Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers. Read the related viewpoint piece in JAMA Neurology. Disclosures can be found at Neurology.org. 

Today I welcome Dr Val to the show the where we talk about a naturopathic approach to mental health and self esteem.

You can find more from Dr Val here:

<a href="https://calendly.com/url?q=https%3A%2F%2Fdrvalfranc.com%2Fabout-dr-val%2F&user_uuid=EFFBOKWFGRE3A ...

Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sp ...  Show more

<img align="right" border="0" src="https://support.doctorpodcasting.com/media/k2/items/cache/64c0eb8919976c07a27649dc11664619_S.jpg" alt="practical-strategies-in-lipid ...  Show more